Cardiovascular diseases are the leading cause of death worldwide and are closely linked to the aging process. As we age, adult stem cells in the heart lose their ability to proliferate and regenerate tissue, which diminishes the heart's overall regenerative capacity. This makes understanding and improving the regenerative potential of human cardiac stem cells (hCSCs) a key area of interest for treating these diseases.
Recent research has shown that human blood serum can significantly enhance the proliferation of hCSCs and reduce their senescence, or aging. This effect appears to be independent of the donor's age and sex, indicating a broad potential application for rejuvenating heart tissue. Studies have identified several signaling pathways involved in this process, including the transcription factor NF-κB and the TGFβ signaling pathway. These pathways help regulate cell proliferation and prevent excessive aging of the cells.